Allos Therapeutics Newswire

Comprehensive Real-Time News Feed for Allos Therapeutics.

Results 1 - 2 of 2 in Allos Therapeutics

  1. Dan Hudspeth Joins SynCardia Systems, Inc. As Chief Financial OfficerRead the original story w/Photo

    Feb 23, 2015 | BioSpace

    ... Strategy LLC. He has served as the chief financial officer of Genomica Corp., Rally Development Corp. and Allos Therapeutics. is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total ...


  2. Just Published: "Allos Therapeutics, Inc. (ALTH) - Pharmaceuticals &...Read the original story

    Jan 3, 2015 |

    Allos Therapeutics, Inc., a biopharmaceutical company, engaged in the development and commercialization of small molecule therapeutics for the treatment of cancer. Its lead product candidate, FOLOTYN , a novel antifolate has completed a pivotal phase 2 trial in patients, a targeted chemotherapeutic agent, treats advanced solid tumors.